Mark Rieder has been appointed to senior vice president of operations at Adaptive Biotechnologies, which is developing sequencing based-assays for the adaptive immune system. Rieder was previously a research professor in human genomics at the University of Washington and also technical director of the Northwest Genomics Center.
He holds a PhD in cardiovascular physiology from the Medical College of Wisconsin and completed a postdoctoral fellowship in genome sciences at the University of Washington.